13F-HR filed by Consonance Capital Management LP
Consonance Capital Management LP filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 8 holding rows worth $58,946,000.
- Accession
- 0001085146-22-002165
- Filer
- CIK 1544773
- Filed
- 2022-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 8 entries on the cover page, a total value of $58,946,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $58,946,000 with VALUE read as thousands by filing date, 13F file number 028-14924. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 147,327 | $17,133,000 | thousands by filing date | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 654,108 | $12,428,000 | thousands by filing date | |
| Surrozen, Inc. | 86889P109 | COM | 3,497,500 | $10,527,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 107,024 | $7,896,000 | thousands by filing date | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 3,500,000 | $4,743,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 24,563 | $4,407,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 137,000 | $1,521,000 | thousands by filing date | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 1,165,832 | $291,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-22-002165 | this filing | 2022-05-16 | acceptance time not in the bulk data set |